Johns Hopkins Diabetes Guide
Toujeo
INDICATIONS
FDA
FDA
- Adults and pediatric patients 6 years and older with type 1 diabetes mellitus (DM1)
- Adults with type 2 diabetes mellitus (DM2)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Hyperglycemia in hospitalized patients (off-label use)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 5, 2022
Citation
Veillard, Régine B, et al. "Toujeo." Johns Hopkins Diabetes Guide, 2022. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547198/6/Toujeo.
Veillard RB, Quartuccio M, Elder S. Toujeo. Johns Hopkins Diabetes Guide. 2022. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547198/6/Toujeo. Accessed June 7, 2023.
Veillard, R. B., Quartuccio, M., & Elder, S. (2022). Toujeo. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547198/6/Toujeo
Veillard RB, Quartuccio M, Elder S. Toujeo [Internet]. In: Johns Hopkins Diabetes Guide. ; 2022. [cited 2023 June 07]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547198/6/Toujeo.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Toujeo
ID - 547198
A1 - Veillard,Régine,Pharm.D.
AU - Quartuccio,Michael,M.D.
AU - Elder,Stacy,Pharm.D.
Y1 - 2022/03/05/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547198/6/Toujeo
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
